![Christos YAPIJAKIS | Head of Unit of Orofacial Genetics | D.M.D., M.S., Ph.D. | National and Kapodistrian University of Athens, Athens | uoa | 1st Department of Pediatrics Christos YAPIJAKIS | Head of Unit of Orofacial Genetics | D.M.D., M.S., Ph.D. | National and Kapodistrian University of Athens, Athens | uoa | 1st Department of Pediatrics](https://www.researchgate.net/publication/354907314/figure/tbl1/AS:1073177174233088@1632876785073/Comparison-between-women-with-normal-cytology-Controls-and-those-with-any-cytology_Q320.jpg)
Christos YAPIJAKIS | Head of Unit of Orofacial Genetics | D.M.D., M.S., Ph.D. | National and Kapodistrian University of Athens, Athens | uoa | 1st Department of Pediatrics
![Cancers | Free Full-Text | Molecular Characterization of a Long-Term Survivor Double Metastatic Non-Small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6 Cancers | Free Full-Text | Molecular Characterization of a Long-Term Survivor Double Metastatic Non-Small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6](https://www.mdpi.com/cancers/cancers-11-00749/article_deploy/html/images/cancers-11-00749-g001.png)
Cancers | Free Full-Text | Molecular Characterization of a Long-Term Survivor Double Metastatic Non-Small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6
![Christos YAPIJAKIS | Head of Unit of Orofacial Genetics | D.M.D., M.S., Ph.D. | National and Kapodistrian University of Athens, Athens | uoa | 1st Department of Pediatrics Christos YAPIJAKIS | Head of Unit of Orofacial Genetics | D.M.D., M.S., Ph.D. | National and Kapodistrian University of Athens, Athens | uoa | 1st Department of Pediatrics](https://www.researchgate.net/profile/Christos-Yapijakis/publication/331334339/figure/fig2/AS:730358479859712@1551142439134/Pedigree-of-Case-1-The-index-patients-are-shown-by-arrows-while-thrombosis-related_Q320.jpg)
Christos YAPIJAKIS | Head of Unit of Orofacial Genetics | D.M.D., M.S., Ph.D. | National and Kapodistrian University of Athens, Athens | uoa | 1st Department of Pediatrics
![Christos YAPIJAKIS | Head of Unit of Orofacial Genetics | D.M.D., M.S., Ph.D. | National and Kapodistrian University of Athens, Athens | uoa | 1st Department of Pediatrics Christos YAPIJAKIS | Head of Unit of Orofacial Genetics | D.M.D., M.S., Ph.D. | National and Kapodistrian University of Athens, Athens | uoa | 1st Department of Pediatrics](https://i1.rgstatic.net/ii/profile.image/895083377332228-1590415915964_Q128/Elisabeth-Kapaki-2.jpg)
Christos YAPIJAKIS | Head of Unit of Orofacial Genetics | D.M.D., M.S., Ph.D. | National and Kapodistrian University of Athens, Athens | uoa | 1st Department of Pediatrics
![Cancers | Free Full-Text | Molecular Characterization of a Long-Term Survivor Double Metastatic Non-Small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6 Cancers | Free Full-Text | Molecular Characterization of a Long-Term Survivor Double Metastatic Non-Small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6](https://www.mdpi.com/cancers/cancers-11-00749/article_deploy/html/images/cancers-11-00749-g002.png)
Cancers | Free Full-Text | Molecular Characterization of a Long-Term Survivor Double Metastatic Non-Small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6
![Christos YAPIJAKIS | Head of Unit of Orofacial Genetics | D.M.D., M.S., Ph.D. | National and Kapodistrian University of Athens, Athens | uoa | 1st Department of Pediatrics Christos YAPIJAKIS | Head of Unit of Orofacial Genetics | D.M.D., M.S., Ph.D. | National and Kapodistrian University of Athens, Athens | uoa | 1st Department of Pediatrics](https://www.researchgate.net/profile/Christos-Yapijakis/publication/331334339/figure/fig4/AS:730358479872000@1551142439171/CT-scan-Osteosclerotic-lesions-in-the-right-mandible-with-the-periosteum-subduction_Q320.jpg)
Christos YAPIJAKIS | Head of Unit of Orofacial Genetics | D.M.D., M.S., Ph.D. | National and Kapodistrian University of Athens, Athens | uoa | 1st Department of Pediatrics
![Christos YAPIJAKIS | Head of Unit of Orofacial Genetics | D.M.D., M.S., Ph.D. | National and Kapodistrian University of Athens, Athens | uoa | 1st Department of Pediatrics Christos YAPIJAKIS | Head of Unit of Orofacial Genetics | D.M.D., M.S., Ph.D. | National and Kapodistrian University of Athens, Athens | uoa | 1st Department of Pediatrics](https://i1.rgstatic.net/ii/profile.image/582307238158336-1515844272354_Q128/Christos-Yapijakis.jpg)
Christos YAPIJAKIS | Head of Unit of Orofacial Genetics | D.M.D., M.S., Ph.D. | National and Kapodistrian University of Athens, Athens | uoa | 1st Department of Pediatrics
![Christos YAPIJAKIS | Head of Unit of Orofacial Genetics | D.M.D., M.S., Ph.D. | National and Kapodistrian University of Athens, Athens | uoa | 1st Department of Pediatrics Christos YAPIJAKIS | Head of Unit of Orofacial Genetics | D.M.D., M.S., Ph.D. | National and Kapodistrian University of Athens, Athens | uoa | 1st Department of Pediatrics](https://i1.rgstatic.net/ii/profile.image/821597191557120-1572895443358_Q128/Christalena-Sofocleous.jpg)
Christos YAPIJAKIS | Head of Unit of Orofacial Genetics | D.M.D., M.S., Ph.D. | National and Kapodistrian University of Athens, Athens | uoa | 1st Department of Pediatrics
![PDF) Molecular Characterization of a Long-Term Survivor Double Metastatic Non-Small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6 as First and Second PDF) Molecular Characterization of a Long-Term Survivor Double Metastatic Non-Small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6 as First and Second](https://i1.rgstatic.net/publication/333469273_Molecular_Characterization_of_a_Long-Term_Survivor_Double_Metastatic_Non-Small_Cell_Lung_Cancer_and_Pancreatic_Ductal_Adenocarcinoma_Treated_with_Gefitinib_in_Combination_with_Gemcitabine_Plus_Nab-Pac/links/5cef540f92851c4dd01a73b3/largepreview.png)
PDF) Molecular Characterization of a Long-Term Survivor Double Metastatic Non-Small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6 as First and Second
![Christos YAPIJAKIS | Head of Unit of Orofacial Genetics | D.M.D., M.S., Ph.D. | National and Kapodistrian University of Athens, Athens | uoa | 1st Department of Pediatrics Christos YAPIJAKIS | Head of Unit of Orofacial Genetics | D.M.D., M.S., Ph.D. | National and Kapodistrian University of Athens, Athens | uoa | 1st Department of Pediatrics](https://www.researchgate.net/profile/Christos-Yapijakis/publication/331334339/figure/fig3/AS:730358479863808@1551142439152/Pedigree-of-Case-2-The-index-patients-are-shown-by-arrows-while-thrombosis-related_Q320.jpg)